Principal Financial Group Inc Agenus Inc Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$0.53 - $0.93 $5,498 - $9,648	-10,375 Reduced 10.25%	90,825 $52,000
Q4 2023 Feb 07, 2024	SELL	$0.63 - $1.14 $3,837 - $6,943	-6,091 Reduced 5.68%	101,200 $83,000
Q3 2023 Nov 02, 2023	BUY	$1.12 - $1.88 $17,214 - $28,895	15,370 Added 16.72%	107,291 $121,000
Q2 2023 Aug 07, 2023	SELL	$1.31 - $2.04 $48,320 - $75,247	-36,886 Reduced 28.64%	91,921 $147,000
Q1 2023 May 09, 2023	SELL	$1.45 - $2.95 $26,321 - $53,551	-18,153 Reduced 12.35%	128,807 $195,000
Q4 2022 Feb 09, 2023	BUY	$2.02 - $3.25 $26 - $42	13 Added 0.01%	146,960 $352,000
Q3 2022 Nov 09, 2022	SELL	$1.96 - $3.14 $264,376 - $423,542	-134,886 Reduced 47.86%	146,947 $302,000
Q2 2022 Aug 10, 2022	SELL	$1.3 - $2.64 $10,332 - $20,982	-7,948 Reduced 2.74%	281,833 $546,000
Q1 2022 May 09, 2022	SELL	$2.35 - $3.47 $262,375 - $387,422	-111,649 Reduced 27.81%	289,781 $713,000
Q4 2021 Feb 09, 2022	SELL	$2.92 - $5.74 $266,782 - $524,429	-91,364 Reduced 18.54%	401,430 $1.29 Million
Q3 2021 Nov 09, 2021	BUY	$4.98 - $6.63 $10,771 - $14,340	2,163 Added 0.44%	492,794 $2.59 Million
Q2 2021 Aug 10, 2021	BUY	$2.56 - $5.49 $661,788 - $1.42 Million	258,511 Added 111.37%	490,631 $2.69 Million
Q1 2021 May 10, 2021	BUY	$2.69 - $5.25 $25,673 - $50,106	9,544 Added 4.29%	232,120 $631,000
Q4 2020 Feb 08, 2021	SELL	$3.17 - $4.49 $128,232 - $181,629	-40,452 Reduced 15.38%	222,576 $708,000
Q3 2020 Nov 06, 2020	BUY	$2.98 - $5.2 $294,972 - $514,716	98,984 Added 60.34%	263,028 $1.05 Million
Q2 2020 Aug 05, 2020	BUY	$2.29 - $4.24 $295,501 - $547,129	129,040 Added 368.64%	164,044 $645,000
Q1 2020 May 12, 2020	SELL	$1.92 - $4.39 $46 - $105	-24 Reduced 0.07%	35,004 $86,000
Q4 2019 Feb 05, 2020	BUY	$2.41 - $4.4 $13,144 - $23,997	5,454 Added 18.44%	35,028 $143,000
Q3 2019 Nov 13, 2019	BUY	$2.17 - $3.14 $6,796 - $9,834	3,132 Added 11.84%	29,574 $76,000
Q2 2019 Aug 12, 2019	BUY	$2.53 - $3.04 $3,562 - $4,280	1,408 Added 5.62%	26,442 $79,000
Q1 2019 May 10, 2019	BUY	$2.51 - $3.73 $2,407 - $3,577	959 Added 3.98%	25,034 $74,000
Q4 2018 Feb 14, 2019	SELL	$1.59 - $2.66 $9,664 - $16,167	-6,078 Reduced 20.16%	24,075 $58,000
Q3 2018 Nov 14, 2018	BUY	$1.59 - $2.42 $8,690 - $13,227	5,466 Added 22.14%	30,153 $64,000
Q2 2018 Aug 13, 2018	SELL	$2.26 - $4.65 $2,598 - $5,347	-1,150 Reduced 4.45%	24,687 $0
Q1 2018 May 14, 2018	BUY	$3.51 - $6.04 $1,214 - $2,089	346 Added 1.36%	25,837 $122,000
Q4 2017 Feb 13, 2018	BUY	$3.26 - $4.78 $46,314 - $67,909	14,207 Added 125.9%	25,491 $83,000
Q3 2017 Nov 02, 2017	BUY	$3.48 - $4.44 $39,268 - $50,100	11,284	11,284 $50,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account